{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,20]],"date-time":"2026-11-20T21:54:44Z","timestamp":1795211684673,"version":"4.10.3"},"reference-count":75,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,29]],"date-time":"2025-03-29T00:00:00Z","timestamp":1743206400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,3,29]],"date-time":"2025-03-29T00:00:00Z","timestamp":1743206400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"DOI":"10.1186\/s12885-025-13972-w","type":"journal-article","created":{"date-parts":[[2025,3,29]],"date-time":"2025-03-29T19:20:10Z","timestamp":1743276010000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Prognostic value of neutrophil-to-lymphocyte ratio in patients with hepatocellular carcinoma receiving curative therapies: a systematic review and meta-analysis"],"prefix":"10.1186","volume":"25","author":[{"given":"Jinxiang","family":"Peng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haozhu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinmei","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,29]]},"reference":[{"issue":"12","key":"13972_CR1","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1038\/s41571-023-00825-3","volume":"20","author":"AG Singal","year":"2023","unstructured":"Singal AG, Kanwal F, Llovet JM. Global trends in hepatocellular carcinoma epidemiology: implications for screening, prevention and therapy. Nat Rev Clin Oncol. 2023;20(12):864\u201384.","journal-title":"Nat Rev Clin Oncol"},{"issue":"1","key":"13972_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3350\/cmh.2023.0125","volume":"30","author":"K Sankar","year":"2024","unstructured":"Sankar K, Gong J, Osipov A, Miles SA, Kosari K, Nissen NN, Hendifar AE, Koltsova EK, Yang JD. Recent advances in the management of hepatocellular carcinoma. Clin Mol Hepatol. 2024;30(1):1\u201315.","journal-title":"Clin Mol Hepatol"},{"issue":"2","key":"13972_CR3","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.ccell.2024.01.007","volume":"42","author":"X Yang","year":"2024","unstructured":"Yang X, Yang C, Zhang S, Geng H, Zhu AX, Bernards R, Qin W, Fan J, Wang C, Gao Q. Precision treatment in advanced hepatocellular carcinoma. Cancer Cell. 2024;42(2):180\u201397.","journal-title":"Cancer Cell"},{"issue":"15","key":"13972_CR4","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1056\/NEJMra065156","volume":"356","author":"PA Clavien","year":"2007","unstructured":"Clavien PA, Petrowsky H, DeOliveira ML, Graf R. Strategies for safer liver surgery and partial liver transplantation. N Engl J Med. 2007;356(15):1545\u201359.","journal-title":"N Engl J Med"},{"issue":"1","key":"13972_CR5","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s13045-024-01549-2","volume":"17","author":"KY Shen","year":"2024","unstructured":"Shen KY, Zhu Y, Xie SZ, Qin LX. Immunosuppressive tumor microenvironment and immunotherapy of hepatocellular carcinoma: current status and prospectives. J Hematol Oncol. 2024;17(1):25.","journal-title":"J Hematol Oncol"},{"issue":"4","key":"13972_CR6","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1038\/s41571-024-00868-0","volume":"21","author":"JM Llovet","year":"2024","unstructured":"Llovet JM, Pinyol R, Yarchoan M, Singal AG, Marron TU, Schwartz M, Pikarsky E, Kudo M, Finn RS. Adjuvant and neoadjuvant immunotherapies in hepatocellular carcinoma. Nat Rev Clin Oncol. 2024;21(4):294\u2013311.","journal-title":"Nat Rev Clin Oncol"},{"key":"13972_CR7","doi-asserted-by":"publisher","first-page":"i4919","DOI":"10.1136\/bmj.i4919","volume":"355","author":"JA Sterne","year":"2016","unstructured":"Sterne JA, Hern\u00e1n MA, Reeves BC, Savovi\u0107 J, Berkman ND, Viswanathan M, Henry D, Altman DG, Ansari MT, Boutron I, et al. ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ. 2016;355:i4919.","journal-title":"BMJ"},{"issue":"4","key":"13972_CR8","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1093\/jnci\/djae021","volume":"116","author":"L O\u2019Connor","year":"2024","unstructured":"O\u2019Connor L, Bailey-Whyte M, Bhattacharya M, Butera G, Hardell KNL, Seidenberg AB, Castle PE, Loomans-Kropp HA. Association of Metformin use and cancer incidence: a systematic review and meta-analysis. J Natl Cancer Inst. 2024;116(4):518\u201329.","journal-title":"J Natl Cancer Inst"},{"key":"13972_CR9","doi-asserted-by":"crossref","unstructured":"Ni HH, Yang XH, Yang CL, Zhang Q, Xu JX, Qi LN, Xiang BD. Combination of Preoperative Circulating Tumor Cell Count and Neutrophil-Lymphocyte Ratio for Prognostic Prediction in Hepatocellular Carcinoma Patients after Curative Hepatectomy. Biomed Res Int. 2022:7305953.","DOI":"10.1155\/2022\/7305953"},{"key":"13972_CR10","doi-asserted-by":"crossref","unstructured":"Chen D, Mao P, Sun C, Fan X, Zhu Q, Chen Z, He Z, Lou Y, Sun H. Prognostic value of combined Neutrophil-to-Lymphocyte ratio and imaging tumor capsule in solitary hepatocellular carcinoma patients after Narrow-Margin hepatectomy. J Clin Med 2024, 13(2).","DOI":"10.3390\/jcm13020351"},{"key":"13972_CR11","doi-asserted-by":"publisher","first-page":"1118053","DOI":"10.3389\/fimmu.2023.1118053","volume":"14","author":"S Cui","year":"2023","unstructured":"Cui S, Cao S, Chen Q, He Q, Lang R. Preoperative systemic inflammatory response index predicts the prognosis of patients with hepatocellular carcinoma after liver transplantation. Front Immunol. 2023;14:1118053.","journal-title":"Front Immunol"},{"key":"13972_CR12","doi-asserted-by":"publisher","first-page":"823054","DOI":"10.3389\/fonc.2021.823054","volume":"11","author":"Z Qu","year":"2021","unstructured":"Qu Z, Lu YJ, Feng JW, Chen YX, Shi LQ, Chen J, Rambaran N, Duan YF, He XZ. Preoperative prognostic nutritional index and Neutrophil-to-Lymphocyte ratio predict survival outcomes of patients with hepatocellular carcinoma after curative resection. Front Oncol. 2021;11:823054.","journal-title":"Front Oncol"},{"issue":"1","key":"13972_CR13","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1186\/s12876-023-02804-5","volume":"23","author":"H Luo","year":"2023","unstructured":"Luo H, Huang C, Meng M, Zhang M, Li Z, Huang J. Combination of neutrophil\/lymphocyte ratio and albumin\/bilirubin grade as a prognostic predictor for hepatocellular carcinoma patients undergoing curative hepatectomy. BMC Gastroenterol. 2023;23(1):162.","journal-title":"BMC Gastroenterol"},{"issue":"1","key":"13972_CR14","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1186\/s12935-021-02204-3","volume":"21","author":"W Wu","year":"2021","unstructured":"Wu W, Wang Q, Han D, Li J, Nie Y, Guo D, Yang L, Tao K, Zhang X, Dou K. Prognostic value of preoperative inflammatory markers in patients with hepatocellular carcinoma who underwent curative resection. Cancer Cell Int. 2021;21(1):500.","journal-title":"Cancer Cell Int"},{"issue":"10","key":"13972_CR15","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1007\/s00270-021-02872-8","volume":"44","author":"Y Chen","year":"2021","unstructured":"Chen Y, Yang Y, Zhang XY, Fan QS, Li X, Xin YJ, Cao XJ, Wang YN, Zhou X. Nomogram based on Neutrophil-to-Lymphocyte ratio and Platelet-to-Lymphocyte ratio to predict recurrence in patients with hepatocellular carcinoma after radiofrequency ablation. Cardiovasc Intervent Radiol. 2021;44(10):1551\u201360.","journal-title":"Cardiovasc Intervent Radiol"},{"issue":"8","key":"13972_CR16","doi-asserted-by":"publisher","first-page":"5800","DOI":"10.3390\/curroncol29080457","volume":"29","author":"J Zhou","year":"2022","unstructured":"Zhou J, Yang D. Changes in inflammatory markers predict the prognosis of resected hepatocellular carcinoma with Child-Pugh A. Curr Oncol. 2022;29(8):5800\u20139.","journal-title":"Curr Oncol"},{"issue":"1","key":"13972_CR17","doi-asserted-by":"publisher","first-page":"8670","DOI":"10.1038\/s41598-022-12518-5","volume":"12","author":"J Wang","year":"2022","unstructured":"Wang J, Chen Z, Wang L, Feng S, Qiu Q, Chen D, Li N, Xiao Y. A new model based inflammatory index and tumor burden score (TBS) to predict the recurrence of hepatocellular carcinoma (HCC) after liver resection. Sci Rep. 2022;12(1):8670.","journal-title":"Sci Rep"},{"issue":"2","key":"13972_CR18","first-page":"2574","volume":"15","author":"Y Cao","year":"2018","unstructured":"Cao Y, Jiang Z, Wang S, Zhang H, Jiang Y, Lv L. Prediction of long-term survival rates in patients undergoing curative resection for solitary hepatocellular carcinoma. Oncol Lett. 2018;15(2):2574\u201382.","journal-title":"Oncol Lett"},{"issue":"3","key":"13972_CR19","doi-asserted-by":"publisher","first-page":"e58184","DOI":"10.1371\/journal.pone.0058184","volume":"8","author":"J Dan","year":"2013","unstructured":"Dan J, Zhang Y, Peng Z, Huang J, Gao H, Xu L, Chen M. Postoperative neutrophil-to-lymphocyte ratio change predicts survival of patients with small hepatocellular carcinoma undergoing radiofrequency ablation. PLoS ONE. 2013;8(3):e58184.","journal-title":"PLoS ONE"},{"issue":"23","key":"13972_CR20","doi-asserted-by":"publisher","first-page":"6212","DOI":"10.1158\/1078-0432.CCR-14-0442","volume":"20","author":"B Hu","year":"2014","unstructured":"Hu B, Yang XR, Xu Y, Sun YF, Sun C, Guo W, Zhang X, Wang WM, Qiu SJ, Zhou J, et al. Systemic immune-inflammation index predicts prognosis of patients after curative resection for hepatocellular carcinoma. Clin Cancer Res. 2014;20(23):6212\u201322.","journal-title":"Clin Cancer Res"},{"issue":"4","key":"13972_CR21","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.4143\/crt.2018.657","volume":"51","author":"Y Wang","year":"2019","unstructured":"Wang Y, Sun K, Shen J, Li B, Kuang M, Cao Q, Peng S. Novel prognostic nomograms based on Inflammation-Related markers for patients with hepatocellular carcinoma underwent hepatectomy. Cancer Res Treat. 2019;51(4):1464\u201378.","journal-title":"Cancer Res Treat"},{"key":"13972_CR22","doi-asserted-by":"publisher","first-page":"e918824","DOI":"10.12659\/MSM.918824","volume":"26","author":"W Kong","year":"2020","unstructured":"Kong W, Xu H, Cheng J, Fang Z, Wang H, Zhang J, Wang X, Dai T, Gao Y. The prognostic role of a combined fibrinogen and Neutrophil-to-Lymphocyte ratio score in patients with resectable hepatocellular carcinoma: A retrospective study. Med Sci Monit. 2020;26:e918824.","journal-title":"Med Sci Monit"},{"key":"13972_CR23","doi-asserted-by":"publisher","first-page":"e7132","DOI":"10.7717\/peerj.7132","volume":"7","author":"D Wang","year":"2019","unstructured":"Wang D, Bai N, Hu X, OuYang XW, Yao L, Tao Y, Wang Z. Preoperative inflammatory markers of NLR and PLR as indicators of poor prognosis in resectable HCC. PeerJ. 2019;7:e7132.","journal-title":"PeerJ"},{"issue":"45","key":"13972_CR24","doi-asserted-by":"publisher","first-page":"8398","DOI":"10.3748\/wjg.v19.i45.8398","volume":"19","author":"GQ Xiao","year":"2013","unstructured":"Xiao GQ, Liu C, Liu DL, Yang JY, Yan LN. Neutrophil-lymphocyte ratio predicts the prognosis of patients with hepatocellular carcinoma after liver transplantation. World J Gastroenterol. 2013;19(45):8398\u2013407.","journal-title":"World J Gastroenterol"},{"issue":"21","key":"13972_CR25","doi-asserted-by":"publisher","first-page":"5088","DOI":"10.3748\/wjg.v22.i21.5088","volume":"22","author":"HJ Yang","year":"2016","unstructured":"Yang HJ, Guo Z, Yang YT, Jiang JH, Qi YP, Li JJ, Li LQ, Xiang BD. Blood neutrophil-lymphocyte ratio predicts survival after hepatectomy for hepatocellular carcinoma: A propensity score-based analysis. World J Gastroenterol. 2016;22(21):5088\u201395.","journal-title":"World J Gastroenterol"},{"issue":"13","key":"13972_CR26","doi-asserted-by":"publisher","first-page":"4138","DOI":"10.1245\/s10434-015-4516-1","volume":"22","author":"AW Chan","year":"2015","unstructured":"Chan AW, Chan SL, Wong GL, Wong VW, Chong CC, Lai PB, Chan HL, To KF. Prognostic nutritional index (PNI) predicts tumor recurrence of very early\/early stage hepatocellular carcinoma after surgical resection. Ann Surg Oncol. 2015;22(13):4138\u201348.","journal-title":"Ann Surg Oncol"},{"issue":"5","key":"13972_CR27","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.medcli.2018.11.010","volume":"153","author":"Y Ren","year":"2019","unstructured":"Ren Y, Fan X, Chen G, Zhou D, Lin H, Cai X. Preoperative C-reactive protein\/albumin ratio to predict mortality and recurrence of patients with hepatocellular carcinoma after curative resection. Med Clin (Barc). 2019;153(5):183\u201390.","journal-title":"Med Clin (Barc)"},{"issue":"2","key":"13972_CR28","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.tranon.2014.02.011","volume":"7","author":"W Liao","year":"2014","unstructured":"Liao W, Zhang J, Zhu Q, Qin L, Yao W, Lei B, Shi W, Yuan S, Tahir SA, Jin J, et al. Preoperative Neutrophil-to-Lymphocyte ratio as a new prognostic marker in hepatocellular carcinoma after curative resection. Transl Oncol. 2014;7(2):248\u201355.","journal-title":"Transl Oncol"},{"issue":"6","key":"13972_CR29","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1002\/jso.24549","volume":"115","author":"T Yang","year":"2017","unstructured":"Yang T, Zhu J, Zhao L, Mai K, Ye J, Huang S, Zhao Y. Lymphocyte to monocyte ratio and neutrophil to lymphocyte ratio are superior inflammation-based predictors of recurrence in patients with hepatocellular carcinoma after hepatic resection. J Surg Oncol. 2017;115(6):718\u201328.","journal-title":"J Surg Oncol"},{"issue":"36","key":"13972_CR30","doi-asserted-by":"publisher","first-page":"e1486","DOI":"10.1097\/MD.0000000000001486","volume":"94","author":"XC Ni","year":"2015","unstructured":"Ni XC, Yi Y, Fu YP, He HW, Cai XY, Wang JX, Zhou J, Cheng YF, Jin JJ, Fan J, et al. Prognostic value of the modified Glasgow prognostic score in patients undergoing radical surgery for hepatocellular carcinoma. Med (Baltim). 2015;94(36):e1486.","journal-title":"Med (Baltim)"},{"issue":"5","key":"13972_CR31","doi-asserted-by":"publisher","first-page":"e2722","DOI":"10.1097\/MD.0000000000002722","volume":"95","author":"SD Lu","year":"2016","unstructured":"Lu SD, Wang YY, Peng NF, Peng YC, Zhong JH, Qin HG, Xiang BD, You XM, Ma L, Li LQ. Preoperative ratio of neutrophils to lymphocytes predicts postresection survival in selected patients with early or intermediate stage hepatocellular carcinoma. Med (Baltim). 2016;95(5):e2722.","journal-title":"Med (Baltim)"},{"issue":"2","key":"13972_CR32","doi-asserted-by":"publisher","first-page":"441","DOI":"10.21037\/tcr.2019.11.29","volume":"9","author":"T Dai","year":"2020","unstructured":"Dai T, Lin G, Deng M, Zhu S, Li H, Yao J, Li H, Liu W, Yang Y, Chen G, et al. The prognostic significance of neutrophil-to-lymphocyte ratio at different time points in patients with hepatocellular carcinoma receiving liver resection. Transl Cancer Res. 2020;9(2):441\u201357.","journal-title":"Transl Cancer Res"},{"issue":"7","key":"13972_CR33","doi-asserted-by":"publisher","first-page":"3039","DOI":"10.1016\/j.asjsur.2024.02.004","volume":"47","author":"M Utsumi","year":"2024","unstructured":"Utsumi M, Inagaki M, Kitada K, Tokunaga N, Yunoki K, Sakurai Y, Okabayashi H, Hamano R, Miyasou H, Tsunemitsu Y, et al. Predictive values of sarcopenia and systemic inflammation-based markers in advanced hepatocellular carcinoma after hepatectomy. Asian J Surg. 2024;47(7):3039\u201347.","journal-title":"Asian J Surg"},{"issue":"9","key":"13972_CR34","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1002\/jhbp.114","volume":"21","author":"K Yamamura","year":"2014","unstructured":"Yamamura K, Sugimoto H, Kanda M, Yamada S, Nomoto S, Nakayama G, Fujii T, Koike M, Fujiwara M, Kodera Y. Comparison of inflammation-based prognostic scores as predictors of tumor recurrence in patients with hepatocellular carcinoma after curative resection. J Hepatobiliary Pancreat Sci. 2014;21(9):682\u20138.","journal-title":"J Hepatobiliary Pancreat Sci"},{"key":"13972_CR35","doi-asserted-by":"crossref","unstructured":"Ohira M, Aoki G, Orihashi Y, Yoshimura K, Toshima T, Hatano E, Eguchi S, Hibi T, Hasegawa K, Umeda Y et al. Japanese living donor liver transplantation criteria for hepatocellular carcinoma: nationwide cohort study. BJS Open 2024, 8(4).","DOI":"10.1093\/bjsopen\/zrae079"},{"issue":"10","key":"13972_CR36","doi-asserted-by":"publisher","first-page":"5537","DOI":"10.21873\/anticanres.11137","volume":"36","author":"N Harimoto","year":"2016","unstructured":"Harimoto N, Yoshizumi T, Shimagaki T, Nagatsu A, Motomura T, Harada N, Okabe H, Itoh S, Ikegami T, Uchiyama H, et al. Inflammation-based prognostic score in patients with living donor liver transplantation for hepatocellular carcinoma. Anticancer Res. 2016;36(10):5537\u201342.","journal-title":"Anticancer Res"},{"issue":"7","key":"13972_CR37","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1002\/bjs.10123","volume":"103","author":"Y Okamura","year":"2016","unstructured":"Okamura Y, Sugiura T, Ito T, Yamamoto Y, Ashida R, Mori K, Uesaka K. Neutrophil to lymphocyte ratio as an indicator of the malignant behaviour of hepatocellular carcinoma. Br J Surg. 2016;103(7):891\u20138.","journal-title":"Br J Surg"},{"issue":"4","key":"13972_CR38","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1159\/000451066","volume":"34","author":"M Shimoda","year":"2017","unstructured":"Shimoda M, Tago K, Kato M, Aoki T, Kubota K. Prognostic factors after curative resection for Single-Lesion hepatocellular carcinoma in patients with normal liver function: A historical cohort study. Dig Surg. 2017;34(4):281\u20138.","journal-title":"Dig Surg"},{"issue":"6","key":"13972_CR39","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1002\/ags3.12286","volume":"3","author":"M Yamamoto","year":"2019","unstructured":"Yamamoto M, Kobayashi T, Kuroda S, Hamaoka M, Okimoto S, Honmyo N, Yamaguchi M, Ohdan H. Verification of inflammation-based prognostic marker as a prognostic indicator in hepatocellular carcinoma. Ann Gastroenterol Surg. 2019;3(6):667\u201375.","journal-title":"Ann Gastroenterol Surg"},{"issue":"6","key":"13972_CR40","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1007\/s00268-015-2982-z","volume":"39","author":"Y Okamura","year":"2015","unstructured":"Okamura Y, Ashida R, Ito T, Sugiura T, Mori K, Uesaka K. Preoperative neutrophil to lymphocyte ratio and prognostic nutritional index predict overall survival after hepatectomy for hepatocellular carcinoma. World J Surg. 2015;39(6):1501\u20139.","journal-title":"World J Surg"},{"key":"13972_CR41","doi-asserted-by":"publisher","first-page":"4239463","DOI":"10.1155\/2019\/4239463","volume":"2019","author":"T Kabir","year":"2019","unstructured":"Kabir T, Ye M, Mohd Noor NA, Woon W, Junnarkar SP, Shelat VG. Preoperative Neutrophil-to-Lymphocyte ratio plus Platelet-to-Lymphocyte ratio predicts the outcomes after curative resection for hepatocellular carcinoma. Int J Hepatol. 2019;2019:4239463.","journal-title":"Int J Hepatol"},{"issue":"6","key":"13972_CR42","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1002\/jso.24197","volume":"113","author":"BK Goh","year":"2016","unstructured":"Goh BK, Kam JH, Lee SY, Chan CY, Allen JC, Jeyaraj P, Cheow PC, Chow PK, Ooi LL, Chung AY. Significance of neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio and prognostic nutrition index as preoperative predictors of early mortality after liver resection for huge (\u2265\u200910\u00a0cm) hepatocellular carcinoma. J Surg Oncol. 2016;113(6):621\u20137.","journal-title":"J Surg Oncol"},{"issue":"3","key":"13972_CR43","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1097\/SLA.0000000000001966","volume":"265","author":"KJ Halazun","year":"2017","unstructured":"Halazun KJ, Najjar M, Abdelmessih RM, Samstein B, Griesemer AD, Guarrera JV, Kato T, Verna EC, Emond JC, Brown RS. Jr.: recurrence after liver transplantation for hepatocellular carcinoma: A new MORAL to the story. Ann Surg. 2017;265(3):557\u201364.","journal-title":"Ann Surg"},{"key":"13972_CR44","doi-asserted-by":"crossref","unstructured":"Ismael MN, Forde J, Milla E, Khan W, Cabrera R. Utility of Inflammatory Markers in Predicting Hepatocellular Carcinoma Survival after Liver Transplantation. Biomed Res Int. 2019:7284040.","DOI":"10.1155\/2019\/7284040"},{"issue":"7","key":"13972_CR45","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1111\/hepr.12019","volume":"43","author":"AR Limaye","year":"2013","unstructured":"Limaye AR, Clark V, Soldevila-Pico C, Morelli G, Suman A, Firpi R, Nelson DR, Cabrera R. Neutrophil-lymphocyte ratio predicts overall and recurrence-free survival after liver transplantation for hepatocellular carcinoma. Hepatol Res. 2013;43(7):757\u201364.","journal-title":"Hepatol Res"},{"issue":"5","key":"13972_CR46","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.3349\/ymj.2016.57.5.1115","volume":"57","author":"XG Hu","year":"2016","unstructured":"Hu XG, Mao W, Park YK, Xu WG, Kim BW, Wang HJ. Blood Neutrophil-to-Lymphocyte ratio predicts tumor recurrence in patients with hepatocellular carcinoma within Milan criteria after hepatectomy. Yonsei Med J. 2016;57(5):1115\u201323.","journal-title":"Yonsei Med J"},{"issue":"21","key":"13972_CR47","doi-asserted-by":"publisher","first-page":"6594","DOI":"10.3748\/wjg.v20.i21.6594","volume":"20","author":"GH Na","year":"2014","unstructured":"Na GH, Kim DG, Han JH, Kim EY, Lee SH, Hong TH, You YK. Inflammatory markers as selection criteria of hepatocellular carcinoma in living-donor liver transplantation. World J Gastroenterol. 2014;20(21):6594\u2013601.","journal-title":"World J Gastroenterol"},{"issue":"1","key":"13972_CR48","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1186\/s12893-022-01779-6","volume":"22","author":"JPM Silva","year":"2022","unstructured":"Silva JPM, Coelho FF, Cassenote AJF, Jeismann VB, Fonseca GM, Kruger JAP, de Meira J\u00fanior JD, Nahas SC, Herman P. Preoperative inflammatory markers as prognostic predictors after hepatocellular carcinoma resection: data from a Western referral center. BMC Surg. 2022;22(1):329.","journal-title":"BMC Surg"},{"key":"13972_CR49","doi-asserted-by":"publisher","first-page":"977","DOI":"10.2147\/CMAR.S161398","volume":"10","author":"D Galun","year":"2018","unstructured":"Galun D, Bogdanovic A, Djokic Kovac J, Bulajic P, Loncar Z, Zuvela M. Preoperative neutrophil-to-lymphocyte ratio as a prognostic predictor after curative-intent surgery for hepatocellular carcinoma: experience from a developing country. Cancer Manag Res. 2018;10:977\u201388.","journal-title":"Cancer Manag Res"},{"issue":"2","key":"13972_CR50","doi-asserted-by":"publisher","first-page":"169","DOI":"10.21037\/hbsn-21-196","volume":"12","author":"MC Tsai","year":"2023","unstructured":"Tsai MC, Yong CC, Lin CC, Lee WC, Wang CC, Hung CH, Chen IH, Cheng YF, Hsiao CC, Hu TH, et al. Living donor liver transplantation for Barcelona clinic liver cancer (BCLC) intermediate-stage hepatocellular carcinoma. Hepatobiliary Surg Nutr. 2023;12(2):169\u201382.","journal-title":"Hepatobiliary Surg Nutr"},{"issue":"1","key":"13972_CR51","doi-asserted-by":"publisher","first-page":"16611","DOI":"10.1038\/s41598-018-34543-z","volume":"8","author":"MO Chu","year":"2018","unstructured":"Chu MO, Shen CH, Chang TS, Xu HW, Yen CW, Lu SN, Hung CH. Pretreatment Inflammation-Based markers predict survival outcomes in patients with early stage hepatocellular carcinoma after radiofrequency ablation. Sci Rep. 2018;8(1):16611.","journal-title":"Sci Rep"},{"key":"13972_CR52","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.euroneuro.2024.07.009","volume":"88","author":"M Solmi","year":"2024","unstructured":"Solmi M, Croatto G, Gupta A, Fabiano N, Wong S, Fornaro M, Schneider LK, Rohani-Montez SC, Fairley L, Smith N, et al. Effects of antipsychotic treatment on cardio-cerebrovascular related mortality in schizophrenia: A subanalysis of a systematic review and meta-analysis with meta-regression of moderators. Eur Neuropsychopharmacol. 2024;88:6\u201320.","journal-title":"Eur Neuropsychopharmacol"},{"key":"13972_CR53","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.3389\/fonc.2019.01557","volume":"9","author":"L Liu","year":"2019","unstructured":"Liu L, Gong Y, Zhang Q, Cai P, Feng L. Prognostic roles of blood inflammatory markers in hepatocellular carcinoma patients taking Sorafenib. A systematic review and Meta-Analysis. Front Oncol. 2019;9:1557.","journal-title":"Front Oncol"},{"key":"13972_CR54","doi-asserted-by":"publisher","first-page":"111477","DOI":"10.1016\/j.intimp.2023.111477","volume":"128","author":"S Lin","year":"2024","unstructured":"Lin S, Wang Y, Cai X, Ye Y, Chen Y. Predictive indicators of immune therapy efficacy in hepatocellular carcinoma based on neutrophil-to-lymphocyte ratio. Int Immunopharmacol. 2024;128:111477.","journal-title":"Int Immunopharmacol"},{"key":"13972_CR55","doi-asserted-by":"crossref","unstructured":"Arvanitakis K, Mitroulis I, Germanidis G. Tumor-Associated neutrophils in hepatocellular carcinoma pathogenesis, prognosis, and therapy. Cancers (Basel) 2021, 13(12).","DOI":"10.3390\/cancers13122899"},{"issue":"1","key":"13972_CR56","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1186\/s12885-024-12074-3","volume":"24","author":"JH Lee","year":"2024","unstructured":"Lee JH, Hong YM. The relationship between tumor-infiltrating neutrophils and clinical outcomes in patients with resectable hepatocellular carcinoma. BMC Cancer. 2024;24(1):327.","journal-title":"BMC Cancer"},{"key":"13972_CR57","doi-asserted-by":"publisher","first-page":"1431211","DOI":"10.3389\/fimmu.2024.1431211","volume":"15","author":"G Du","year":"2024","unstructured":"Du G, Dou C, Sun P, Wang S, Liu J, Ma L. Regulatory T cells and immune escape in HCC: Understanding the tumor microenvironment and advancing CAR-T cell therapy. Front Immunol. 2024;15:1431211.","journal-title":"Front Immunol"},{"issue":"1","key":"13972_CR58","doi-asserted-by":"publisher","first-page":"57","DOI":"10.3892\/ol.2020.12319","volume":"21","author":"GQ Hong","year":"2021","unstructured":"Hong GQ, Cai D, Gong JP, Lai X. Innate immune cells and their interaction with T cells in hepatocellular carcinoma. Oncol Lett. 2021;21(1):57.","journal-title":"Oncol Lett"},{"key":"13972_CR59","doi-asserted-by":"publisher","first-page":"656908","DOI":"10.3389\/fimmu.2021.656908","volume":"12","author":"D Laha","year":"2021","unstructured":"Laha D, Grant R, Mishra P, Nilubol N. The role of tumor necrosis factor in manipulating the immunological response of tumor microenvironment. Front Immunol. 2021;12:656908.","journal-title":"Front Immunol"},{"issue":"1","key":"13972_CR60","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/s12929-019-0568-z","volume":"26","author":"Y Chen","year":"2019","unstructured":"Chen Y, Song Y, Du W, Gong L, Chang H, Zou Z. Tumor-associated macrophages: an accomplice in solid tumor progression. J Biomed Sci. 2019;26(1):78.","journal-title":"J Biomed Sci"},{"issue":"20","key":"13972_CR61","doi-asserted-by":"publisher","first-page":"e2400303","DOI":"10.1002\/adhm.202400303","volume":"13","author":"Y Jiang","year":"2024","unstructured":"Jiang Y, Nie D, Hu Z, Zhang C, Chang L, Li Y, Li Z, Hu W, Li H, Li S, et al. Macrophage-Derived nanosponges adsorb cytokines and modulate macrophage polarization for renal cell carcinoma immunotherapy. Adv Healthc Mater. 2024;13(20):e2400303.","journal-title":"Adv Healthc Mater"},{"issue":"11","key":"13972_CR62","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/S1471-4906(02)02302-5","volume":"23","author":"A Mantovani","year":"2002","unstructured":"Mantovani A, Sozzani S, Locati M, Allavena P, Sica A. Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol. 2002;23(11):549\u201355.","journal-title":"Trends Immunol"},{"key":"13972_CR63","doi-asserted-by":"publisher","first-page":"1429812","DOI":"10.3389\/fimmu.2024.1429812","volume":"15","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, Han G, Gu J, Chen Z, Wu J. Role of tumor-associated macrophages in hepatocellular carcinoma: impact, mechanism, and therapy. Front Immunol. 2024;15:1429812.","journal-title":"Front Immunol"},{"key":"13972_CR64","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1186\/1478-811X-11-97","volume":"11","author":"CH Heldin","year":"2013","unstructured":"Heldin CH. Targeting the PDGF signaling pathway in tumor treatment. Cell Commun Signal. 2013;11:97.","journal-title":"Cell Commun Signal"},{"key":"13972_CR65","doi-asserted-by":"crossref","unstructured":"Losurdo A, Di Muzio A, Cianciotti BC, Dipasquale A, Persico P, Barigazzi C, Bono B, Feno S, Pessina F, Santoro A et al. T cell features in glioblastoma May guide therapeutic strategies to overcome microenvironment immunosuppression. Cancers (Basel) 2024, 16(3).","DOI":"10.3390\/cancers16030603"},{"issue":"1","key":"13972_CR66","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.bpg.2012.01.017","volume":"26","author":"EL de Mare-Bredemeijer","year":"2012","unstructured":"de Mare-Bredemeijer EL, Metselaar HJ. Optimization of the use of calcineurin inhibitors in liver transplantation. Best Pract Res Clin Gastroenterol. 2012;26(1):85\u201395.","journal-title":"Best Pract Res Clin Gastroenterol"},{"issue":"3","key":"13972_CR67","first-page":"Cd011639","volume":"3","author":"M Rodr\u00edguez-Per\u00e1lvarez","year":"2017","unstructured":"Rodr\u00edguez-Per\u00e1lvarez M, Guerrero-Misas M, Thorburn D, Davidson BR, Tsochatzis E, Gurusamy KS. Maintenance immunosuppression for adults undergoing liver transplantation: a network meta-analysis. Cochrane Database Syst Rev. 2017;3(3):Cd011639.","journal-title":"Cochrane Database Syst Rev"},{"issue":"5","key":"13972_CR68","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1038\/s41575-020-00395-0","volume":"18","author":"JM Llovet","year":"2021","unstructured":"Llovet JM, De Baere T, Kulik L, Haber PK, Greten TF, Meyer T, Lencioni R. Locoregional therapies in the era of molecular and immune treatments for hepatocellular carcinoma. Nat Rev Gastroenterol Hepatol. 2021;18(5):293\u2013313.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"13972_CR69","doi-asserted-by":"crossref","unstructured":"Jim\u00e9nez-Castro MB, Cornide-Petronio ME, Gracia-Sancho J, Peralta C. Inflammasome-Mediated inflammation in liver Ischemia-Reperfusion injury. Cells 2019, 8(10).","DOI":"10.3390\/cells8101131"},{"key":"13972_CR70","doi-asserted-by":"publisher","first-page":"111936","DOI":"10.1016\/j.intimp.2024.111936","volume":"132","author":"H Wang","year":"2024","unstructured":"Wang H, Yang R, Liu D, Li W. Association of pretreatment neutrophil-to-lymphocyte ratio with clinical outcomes in cancer immunotherapy: an evidence synthesis from 30 meta-analyses. Int Immunopharmacol. 2024;132:111936.","journal-title":"Int Immunopharmacol"},{"key":"13972_CR71","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1186\/s12885-016-2189-1","volume":"16","author":"F Ji","year":"2016","unstructured":"Ji F, Liang Y, Fu SJ, Guo ZY, Shu M, Shen SL, Li SQ, Peng BG, Liang LJ, Hua YP. A novel and accurate predictor of survival for patients with hepatocellular carcinoma after surgical resection: the neutrophil to lymphocyte ratio (NLR) combined with the aspartate aminotransferase\/platelet count ratio index (APRI). BMC Cancer. 2016;16:137.","journal-title":"BMC Cancer"},{"key":"13972_CR72","doi-asserted-by":"publisher","first-page":"3879","DOI":"10.2147\/JIR.S325600","volume":"14","author":"J Mei","year":"2021","unstructured":"Mei J, Sun XQ, Lin WP, Li SH, Lu LH, Zou JW, Wei W, Guo RP. Comparison of the prognostic value of Inflammation-Based scores in patients with hepatocellular carcinoma after Anti-PD-1 therapy. J Inflamm Res. 2021;14:3879\u201390.","journal-title":"J Inflamm Res"},{"issue":"12","key":"13972_CR73","doi-asserted-by":"publisher","first-page":"e053061","DOI":"10.1136\/bmjopen-2021-053061","volume":"11","author":"L Lu","year":"2021","unstructured":"Lu L, Lin K, Zheng J, Wu H, Li D. Glasgow prognostic score and modified Glasgow prognostic score and survival in patients with hepatocellular carcinoma: a meta-analysis. BMJ Open. 2021;11(12):e053061.","journal-title":"BMJ Open"},{"key":"13972_CR74","doi-asserted-by":"crossref","unstructured":"Kaibori M, Hiraoka A, Iida H, Komeda K, Hirokawa F, Ueno M, Kosaka H, Matsui K, Sekimoto M. Comparison of the New Neo-Glasgow Prognostic Score Based on the Albumin-Bilirubin Grade with Currently Used Nutritional Indices for Prognostic Prediction following Surgical Resection of Hepatocellular Carcinoma: A Multicenter Retrospective Study in Japan. Cancers (Basel). 2022;14(9).","DOI":"10.3390\/cancers14092091"},{"key":"13972_CR75","doi-asserted-by":"crossref","unstructured":"Kotsifa E, Machairas N, Angelis A, Nikiteas NI, Dimitroulis D, Sotiropoulos GC. Decoding the prognostic significance and therapeutic implications of Inflammation-Based scores in hepatocellular carcinoma: A comprehensive review. Cancers (Basel) 2024, 16(14).","DOI":"10.3390\/cancers16142549"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-13972-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-025-13972-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-13972-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,31]],"date-time":"2025-03-31T20:25:50Z","timestamp":1743452750000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-025-13972-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,29]]},"references-count":75,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["13972"],"URL":"https:\/\/doi.org\/10.1186\/s12885-025-13972-w","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,29]]},"assertion":[{"value":"22 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"571"}}